- Treatment with statins doesn´t lower the cardiovascular morbidity and mortality - results of AURORA study. Commentary on: NEJM 360,2009,1395-14072009 | First Faculty of Medicine
- Change of cardiovascular morbidity and mortality trends in 1989 - 19992001 | Second Faculty of Medicine
- Social and Economic changes and cardiovascular morbidity and mortality trends in czech Republic.1997 | Faculty of Physical Education and Sport
- Normalization of hemoglobin doesn´t lower cardiovascular morbidity and mortality in patients with chronic kidney disease2006 | First Faculty of Medicine
- By inhibition of angiotensin konverting enzyme to beneficial effect on endothelial function and reduction of cardiovascular morbidity and mortality2003 | First Faculty of Medicine
- Pharmacotherapy of diabetes: nephrologist's perspective +12017 | First Faculty of Medicine
- The determinants of blood pressure response to exercise2015 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Hypertension in end-stage renal disease: Transplantation2018 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Hypertension in End-Stage Kidney Disease: Transplantation2023 | Second Faculty of Medicine
- The Importance of Ambulatory Blood Pressure Monitoring in Hypertension Control of Patients With IgA Nephropathy2012 | First Faculty of Medicine
- Peroral antidiabetic drugs and cardiovascular risk2007 | Faculty of Medicine in Pilsen
- Peroral antidiabetic drugs and cardiovascular risk2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- News in the treatment of diabetes2011 | First Faculty of Medicine
- Possible gene-gender interaction between the SLC01B1 polymorphism and statin treatment efficacy2012 | First Faculty of Medicine
- Current trends, news and developments in lipid-lowering therapy in terms of individual groups of pharmaceuticals, their combinations and new technologies2012 | Faculty of Medicine in Hradec Králové
- 25 years of statins: What happened in the 25 years since the introduction of lovastatin on the market and in clinical practice2012 | First Faculty of Medicine
- Where is Achilles heel of statins and how to treat it?2012 | First Faculty of Medicine
- Epidemiology of cardiovascular diseases2010 | Faculty of Medicine in Pilsen
- Metabolic surgery in prevention and therapy of cardiovascular events2014 | First Faculty of Medicine
- Commentary to the new analysis of IMPROVE-IT study concerning achievment of dual goals LDL-cholesterol nad C reactive protein2015 | Faculty of Medicine in Pilsen
- Antidiabetics and cardiovascular risk2018 | First Faculty of Medicine
- Care of patients with hypothyroidism and cardiovascular disease2019 | First Faculty of Medicine
- Results of large cardiology-diabetic studies in recent years (EXAMINE, ORIGIN, SAVOR)2014 | Second Faculty of Medicine
- Cardiovascular endocrinology: Heart and endocrine diseases2021 | First Faculty of Medicine
- Statins as a standard for therapy of diabetics type 2 - subanalysis of Heart Protection Study2004 | Second Faculty of Medicine
- Management of Massive Pulmonary Embolism2022 | Publication without faculty affiliation
- Subclinical thyroid disease2021 | Third Faculty of Medicine
- Lipid metabolism disorders in the patiens with chronic renal disease and the possibilities of hypolipidemic therapy2010 | Faculty of Medicine in Hradec Králové
- Effect of atorvastatin on non-cholesterol sterol in patients with type 2 diabetes mellitus and cardiovascular disease2005 | Publication without faculty affiliation